Presentations & Publications
2020
- Invasive Pulmonary Aspergillosis treatment duration in haematology patients in Europe: an EFISG, IDWP‐EBMT, EORTC‐IDG, SEIFEM survey
Lanternier F, Seidel D, Pagano L, et al. Mycoses 2020. doi: 10.1111/myc.13056 - MixInYeast: A Multicenter Study on Mixed Yeast Infections
Medina N, Soto-Debrán JC, Seidel D et al. J Fungi (Basel) 2020; 7:13. doi: 10.3390/jof7010013
2019
EFISG & ESGICH
- Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: results of an international practice survey from ESCMID Fungal Infection Study Group and Study Group for Infections in Compromised Hosts, and European Confederation of Medical Mycology.
Rammaert B, Puyade M, Cornely OA et al. Transpl Infect Dis 2019:e13141. doi: 10.1111/tid.13141.
ESGCIP & EFISG & ESCMID
- Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project.
Bassetti M, Scudeller L, Giacobbe DR et al. Mycoses 2019;62:310-319. doi: 10.1111/myc.12869.
2018
- Azole-resistance in Aspergillus terreus and related species: an emerging problem
or a rare phenomenon?
Zoran T, Sartori B, Sappl L et al. Front Microbiol 2018;9:516. doi: 10.3389/fmicb.2018.00516.
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Ullman et al., CMI 2018;24e1-e38
This paper has the goal to provide a comprehensive European guideline focusing on the life-threatening diseases caused by Aspergillus spp. It is the third fungal diagnosis and management clinical guideline published in cooperation with various European scientific societies. This part of the guideline regarding invasive and chronic aspergillosis is a condensation of all the recommendations made by the guideline subcommittees and is presented in tables for easier and faster reading.
2017
A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study. Risslegger et al., CMI 2017;23:776.e1-776.e5.
The aim of this study was to investigate the global prevalence of Aspergillus terreus species complex in fungal diseases and to survey amphotericin B susceptibility. A. terreus is a common cause of invasive aspergillosis at the M. D. Anderson Cancer Center in Houston, TX, USA, and the University Hospital of Innsbruck, Austria. Almost no data were available on how frequently this species occurs elsewhere and whether differences within amphotericin B susceptibility exist. The results of this prospective international multicentre surveillance study show that the overall prevalence of A. terreus species complex among the investigated patients with mould-positive cultures was 5.2% (370 cases/7116, data from 21 countries). Amphotericin B MICs ranged from 0.125 to 32 mg/L, (median 8 mg/L).
2014
ESCMID and ECMM guidelines for the management of rare and emerging fungal infections
Clin Microbiol Infect 2014; 20 (Suppl. 3)
- Editorial
- ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013
- ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others
- ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi
- ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections
2013
ESCMID PGEC Antifungal Resistance and its Challenges in the Management of Invasive Fungal Infections
Sibiu, Romania, June 2013
2012
ESCMID guideline for the diagnosis and management of Candida diseases 2012
Clin Microbiol Infect 2012; 18 (Suppl. 7)
- Developing European guidelines in clinical microbiology and infectious diseases
- Diagnostic procedures
- Non-neutropenic adult patients
- Prevention and management of invasive infections in neonates and children caused by Candida spp.
- Adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
- Patients with HIV infection or AIDS
ESCMID PGEC Problems in the Diagnosis and Treatment of Invasive Fungal Infections: Recent Advances in Their Management
Athens, Greece, March 2012
2011
ESCMID PGEC Aspergillosis: from Allergy to Invasive Disease
Manchester, UK, May 2011
Course material in the ESCMID OLL
ESCMID PGEC Biofilms in Nosocomial Fungal Infections
Paris, France, February 2011
ESCMID Postgraduate Education Course Presentations available
Invasive Fungal Infections: Host - Pathogen Interactions
EFISG organized this ESCMID PGEC in Oslo, Norway, 16 - 17 March 2010.
ESCMID Conference Webcasts available
Invasive Fungal Infections
Rome, Italy, 18 - 19 February 2010.
Webcast of all talks are available for ESCMID members!
ESCMID Postgraduate Education Course Presentations available
Diagnosing and Treating Fungal Infections: from Neonates to Adults
EFISG organized this ESCMID PGEC in Thessaloniki, Greece 22 - 24 October 2009.
Molecular identification of Zygomycetes species
A collaborative ESCMID Fungal Infection Study Group project (Lortholary and Dannaoui). Publication in preparation.
EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia–forming moulds
EFISG in cooperation with EUCAST Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST).
Clin Microbiol Infect. 2008; 14(10):982-4
EUCAST technical note on voriconazole
EFISG in cooperation with EUCAST Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST).
Clin Microbiol Infect. 2008; 14(10):985-7
Method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts
EUCAST Definitive Document EDef 7.1
EFISG in cooperation with EUCAST Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST).
Clin Microbiol Infect. 2008; 14(4):398 - 405
EUCAST technical note on fluconazole
European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST).
Clin Microbiol Infect. 2008, 14 (2):193-5
Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)
Cuenca-Estrella M, Arendrup MC, Chryssanthou E, Dannaoui E, Lass-Florl C, Sandven P, Velegraki A, Rodriguez-Tudela JL; AFST Subcommittee of EUCAST. Clin Microbiol Infect. 2007, 13 (10): 1018-22
Poster ECCMID 2007:
Survey of mycology laboratory practice across Europe Bille, Atherton, Lortholary, Voss, Denning and the ESCMID Fungal Infection Study Group
CMI Website
eAcademy
EUCAST
